Updated on 20 January 2014
Chinese officials have widened investigations to now target domestic drug makers
Singapore: In a bid to expand the pharma corruption investigations, Chinese officials have detained the former Sinopharm vice president following corruption charges
Targeting domestic drug makers now, China's crackdown on the pharma industry shifted gears when EU leaders slammed the country for targeting only foreign drug makers.
Authorities in Shanghai have detained a former vice president of China's biggest drug maker, Sinopharm, as part of a corruption probe.
A Bloomberg report stated that authorities had taken in Shi Jinming, a former vice president who resigned last month for personal reasons. Xu Yizhong, former general manager of a Sinopharm distribution unit, is also said to be involved.
The report pointed out that a whistleblower had accused the two of misappropriating company money and creating illegal personal accounts.
Chinese companies like Gan & Lee and Sino Biopharm were also probed by authorities late last year.